These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8093908)

  • 21. Characterization of the ocular antiallergic and antihistaminic effects of olopatadine (AL-4943A), a novel drug for treating ocular allergic diseases.
    Sharif NA; Xu SX; Miller ST; Gamache DA; Yanni JM
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1252-61. PubMed ID: 8819509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Binding of a radioiodinated agonist to thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptors in guinea pig lung membranes.
    Mais DE; Saussy DL; Magee DE; Williams CM
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():347-50. PubMed ID: 1825567
    [No Abstract]   [Full Text] [Related]  

  • 23. Agonist-induced phosphorylation of human platelet TXA2/PGH2 receptors.
    Okwu AK; Mais DE; Halushka PV
    Biochim Biophys Acta; 1994 Mar; 1221(1):83-8. PubMed ID: 8130280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dibenz[b,e]oxepinalkanoic acids as nonsteroidal antiinflammatory agents. 1. 6,11-Dihydro-11-oxodibenz]b,e]oxepin-2-acetic acids.
    Aultz DE; Helsley GC; Hoffman D; McFadden AR
    J Med Chem; 1977 Jan; 20(1):66-70. PubMed ID: 833828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences in activities of thromboxane A2 receptor antagonists in smooth muscle cells.
    Miki I; Kase H; Ishii A
    Eur J Pharmacol; 1992 Oct; 227(2):199-204. PubMed ID: 1426029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 7-[(1R,2S,3S,5R)-6,6-dimethyl-3-(4- iodobenzenesulfonylamino)bicyclo[3.1.1]hept-2-yl]-5(Z)-heptenoic acid: a novel high-affinity radiolabeled antagonist for platelet thromboxane A2/prostaglandin H2 receptors.
    Naka M; Mais DE; Morinelli TA; Hamanaka N; Oatis JE; Halushka PV
    J Pharmacol Exp Ther; 1992 Aug; 262(2):632-7. PubMed ID: 1386885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiplatelet effects of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e] oxepine-2-carboxylate monohydrate.
    Karasawa A; Kawakage M; Shirakura S; Higo K; Kubo K; Ohshima E; Obase H
    Arzneimittelforschung; 1991 Dec; 41(12):1230-6. PubMed ID: 1840011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of a thromboxane A2/prostaglandin H2 receptor in guinea pig lung membranes using a radioiodinated thromboxane mimetic.
    Saussy DL; Mais DE; Dubé GP; Magee DE; Brune KA; Kurtz WL; Williams CM
    Mol Pharmacol; 1991 Jan; 39(1):72-8. PubMed ID: 1824791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet thromboxane A2/prostaglandin H2 receptors in human volunteers on low doses of aspirin.
    Covatto RH; Niewiarowski S
    Biochem Pharmacol; 1990 Oct; 40(7):1559-61. PubMed ID: 2145839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiasthmatic activity of a novel thromboxane A2 antagonist, S-1452, in guinea pigs.
    Arimura A; Asanuma F; Kurosawa A; Harada M
    Int Arch Allergy Immunol; 1992; 98(3):239-46. PubMed ID: 1392626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of vascular and platelet thromboxane A2/prostaglandin H2 receptors in the pig.
    Mihara S; Hara S; Ueda M; Ide M; Fujimoto M
    Eur J Pharmacol; 1989 Feb; 160(3):313-21. PubMed ID: 2523812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of cyclic flow variations in stenosed canine coronary arteries by thromboxane A2/prostaglandin H2 receptor antagonists.
    Ashton JH; Schmitz JM; Campbell WB; Ogletree ML; Raheja S; Taylor AL; Fitzgerald C; Buja LM; Willerson JT
    Circ Res; 1986 Nov; 59(5):568-78. PubMed ID: 3542279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of binding of a specific antagonist, [3H]-SQ 29,548, to soluble thromboxane A2/prostaglandin H2 (TP) receptors in human platelet membranes.
    Monshizadegan H; Hedberg A; Webb ML
    Life Sci; 1992; 51(6):431-7. PubMed ID: 1386132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thromboxane A2 receptor antagonists. II. Synthesis and pharmacological activity of 6,6-dimethylbicyclo[3.1.1]heptane derivatives with the benzenesulfonylamino group.
    Seno K; Hagishita S
    Chem Pharm Bull (Tokyo); 1989 Apr; 37(4):948-54. PubMed ID: 2527624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biosynthesis and pharmacological modulation of thromboxane in humans.
    Patrono C
    Circulation; 1990 Jan; 81(1 Suppl):I12-5; discussion I22-3. PubMed ID: 2136814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 7-Oxabicyclo[2.2.1]heptane analogs as modulators of the thromboxane A2 and prostacyclin receptors.
    Sprague PW; Heikes JE; Harris DN; Greenberg R
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():337-43. PubMed ID: 6303073
    [No Abstract]   [Full Text] [Related]  

  • 37. Synthesis and dual antagonistic activity against thromboxane A2 and leukotriene D4 of [4-[1-(benzenesulfonamido)alkyl]phenyl]alkanoic acid derivatives.
    Sakurai S; Ogawa N; Onogi Y; Takeshita M; Takahashi H; Ohashi T; Kato K; Yasuda S; Kato H
    Chem Pharm Bull (Tokyo); 1997 May; 45(5):849-62. PubMed ID: 9178522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thromboxane A2 synthetase inhibitors with histamine H1-blocking activity: synthesis and evaluation of a new series of indole derivatives.
    Kamiya S; Matsui H; Shirahase H; Nakamura S; Wada K; Kanda M; Shimaji H; Kakeya N
    Chem Pharm Bull (Tokyo); 1995 Oct; 43(10):1692-5. PubMed ID: 8536342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and evaluation of trimetoquinol derivatives: novel thromboxane A2/prostaglandin H2 antagonists with diminished beta-adrenergic agonist activity.
    Christoff JJ; Bradley L; Miller DD; Lei L; Rodriguez F; Fraundorfer P; Romstedt K; Shams G; Feller DR
    J Med Chem; 1997 Jan; 40(1):85-91. PubMed ID: 9016331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterogeneity of prostaglandin H2/thromboxane A2 receptors: distinct subtypes mediate vascular smooth muscle contraction and platelet aggregation.
    Furci L; Fitzgerald DJ; Fitzgerald GA
    J Pharmacol Exp Ther; 1991 Jul; 258(1):74-81. PubMed ID: 1830100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.